title: In Reply: Cho et al.
authors.affiliation: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School and, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Rishi J
authors.initials: RJ
authors.lastname: Desai
authors.forename: Sonia
authors.initials: S
authors.lastname: Hernandez-Diaz
authors.forename: Brian T
authors.initials: BT
authors.lastname: Bateman
authors.forename: Krista F
authors.initials: KF
authors.lastname: Huybrechts
mesh_terms: D000701:Analgesics, Opioid; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008484:Medicaid / Q000706:statistics & numerical data*; D011247:Pregnancy
chemical_list: D000701:Analgesics, Opioid